Delivery Order SPE2DB22D3301-SPE2DB25FY9ES
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,055.82 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed price delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive, non-set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $8,815.75 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed price delivery order, issued on August 12, 2025, with ultimate completion by August 13, 2025, represents a single procurement under the company's larger indefinite delivery contract with DLA. The award was made on a competitive, non-set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $17,846.50 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract, executed on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $20,761.43 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract is a firm fixed price delivery order with no set-aside designation, awarded competitively on June 2, 2025, with an ultimate completion date of June 3, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $17,970.20 delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, and utilizes firm fixed pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $28,511.98 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract, awarded on August 11, 2025, with completion targeted for August 12, 2025, utilized firm fixed pricing with no set-aside designation, indicating competitive award to the qualified vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $20,371.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The award, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a non-set-aside competitive contract. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $11,630.84 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a non-competitive award under AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $14,110.96 to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price, non-set-aside delivery order was awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency awarded a delivery order valued at $3,594.04 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used to treat rheumatoid arthritis and other autoimmune conditions. The contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, utilizes firm fixed pricing with no set-aside designation, indicating open competition. The product will be supplied to the place of performance in Conshohocken,...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY9ESDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $83,196.81 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, awarded on August 11, 2025, represents a non-set-aside competitive award and is expected to reach completion by August 12, 2025. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and other federal healthcare systems. AmerisourceBergen's track record of competitive awards across multiple therapeutic domains demonstrates its capability to fulfill federal medical procurement requirements efficiently.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $83.2k | 8/11/25 |